Javascript must be enabled to continue!
Enhancing Glioblastoma Resection with NIR Fluorescence Imaging: A Systematic Review
View through CrossRef
Glioblastoma (GB) is among the most aggressive and difficult-to-treat brain tumors, with a median survival of only 12–15 months despite maximal treatments, including surgery, radiotherapy, and chemotherapy. Extensive surgical resection improves survival in glioblastoma patients; however, achieving complete resection is often hindered by limitations in neurosurgical guidance technologies for accurate tumor margin detection. Recent advancements in fluorescence-guided surgery (FGS) and imaging techniques have significantly enhanced the precision and extent of glioblastoma resections. This study evaluates the impact of NIR fluorescence imaging on tumor visualization, surgical precision, cost-effectiveness, and patient survival. A systematic review of PubMed, Scopus, Google Scholar, and Embase was conducted to identify studies on the role of NIR fluorescence in glioblastoma surgery. A total of 135 studies were included, comprising 10 reviews, three clinical studies, 10 randomized controlled trials (RCTs), 10 preclinical studies, and four case reports, all focused on NIR fluorescence imaging in glioblastoma surgery. The findings indicate that NIR fluorescence imaging significantly improves tumor visualization, resulting in an 18–22% increase in gross total resection (GTR) rates in clinical studies. NIR fluorescence provides continuous real-time feedback, minimizing repeat imaging, reducing operational costs, and increasing GTR. These improvements contribute to better patient outcomes, including extended progression-free survival, improved overall survival, and reduced postoperative neurological deficits. This review underscores the potential of NIR imaging to establish a new standard for intraoperative glioblastoma management.
Title: Enhancing Glioblastoma Resection with NIR Fluorescence Imaging: A Systematic Review
Description:
Glioblastoma (GB) is among the most aggressive and difficult-to-treat brain tumors, with a median survival of only 12–15 months despite maximal treatments, including surgery, radiotherapy, and chemotherapy.
Extensive surgical resection improves survival in glioblastoma patients; however, achieving complete resection is often hindered by limitations in neurosurgical guidance technologies for accurate tumor margin detection.
Recent advancements in fluorescence-guided surgery (FGS) and imaging techniques have significantly enhanced the precision and extent of glioblastoma resections.
This study evaluates the impact of NIR fluorescence imaging on tumor visualization, surgical precision, cost-effectiveness, and patient survival.
A systematic review of PubMed, Scopus, Google Scholar, and Embase was conducted to identify studies on the role of NIR fluorescence in glioblastoma surgery.
A total of 135 studies were included, comprising 10 reviews, three clinical studies, 10 randomized controlled trials (RCTs), 10 preclinical studies, and four case reports, all focused on NIR fluorescence imaging in glioblastoma surgery.
The findings indicate that NIR fluorescence imaging significantly improves tumor visualization, resulting in an 18–22% increase in gross total resection (GTR) rates in clinical studies.
NIR fluorescence provides continuous real-time feedback, minimizing repeat imaging, reducing operational costs, and increasing GTR.
These improvements contribute to better patient outcomes, including extended progression-free survival, improved overall survival, and reduced postoperative neurological deficits.
This review underscores the potential of NIR imaging to establish a new standard for intraoperative glioblastoma management.
Related Results
Investigating the role of the apelinergic system in glioblastoma
Investigating the role of the apelinergic system in glioblastoma
<p>Elucidating the molecular signalling circuitry that underpins the pathogenesis of cancers is critical to understanding and developing effective treatment paradigms for can...
Enhancing Glioblastoma Resection with Near-Infrared Fluorescence Imaging: A Systematic Review
Enhancing Glioblastoma Resection with Near-Infrared Fluorescence Imaging: A Systematic Review
Glioblastoma Multiforme (GBM) remains one of the most aggressive and challenging brain tumors to treat. Even with maximal treatment, the prognosis remains poor with low median surv...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical activi...
Glioblastoma: Características Histopatológicas e Marcadores Diagnósticos
Glioblastoma: Características Histopatológicas e Marcadores Diagnósticos
O glioblastoma representa a neoplasia maligna primária mais comum e agressiva do sistema nervoso central em adultos, caracterizando-se por um comportamento biológico altamente infi...
Understanding glioblastoma : cell identity in tissue space
Understanding glioblastoma : cell identity in tissue space
<p dir="ltr"><b>Abstract</b></p><p dir="ltr">Glioblastoma is the most prevalent form of brain cancer among adults. Inherently malignant and aggressive...
Understanding glioblastoma : cell identity in tissue space
Understanding glioblastoma : cell identity in tissue space
<p dir="ltr"><b>Abstract</b></p><p dir="ltr">Glioblastoma is the most prevalent form of brain cancer among adults. Inherently malignant and aggressive...
Endoscope-assisted fluorescence-guided resection allowing supratotal removal in glioblastoma surgery
Endoscope-assisted fluorescence-guided resection allowing supratotal removal in glioblastoma surgery
OBJECTIVE
Several studies have proven the benefits of a wide extent of resection (EOR) of contrast-enhancing tumor in terms of progression-free survival (PFS) a...
In vivo deep brain multiphoton fluorescence imaging emitting at NIR‐I and NIR‐II and excited at NIR‐IV
In vivo deep brain multiphoton fluorescence imaging emitting at NIR‐I and NIR‐II and excited at NIR‐IV
AbstractMultiphoton microscopy (MPM) enables deep brain imaging. Three optical windows: NIR‐I, NIR‐II, and NIR‐III are widely used. Recently, NIR‐IV (the 2200 nm window) has been d...

